Showing results (421-430 of 606) with videos related to

Sort By:
Pageof 61
European Heart Journal|August 19, 2005
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-upDebabrata Mukherjee, Eric J Topol, Michel E Bertrand, et al.
The New England Journal of Medicine|June 23, 2001
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularizationE J Topol, D J Moliterno, H C Herrmann, et al.
Cytotherapy|August 5, 2018
Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host diseaseAbel Trujillo-Ocampo, Hyun-Woo Cho, Amanda C Herrmann, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 22, 2014
Rationale, development, implementation, and initial results of a fast track protocol for transfemoral transcatheter aortic valve replacement (TAVR)Rebecca Marcantuono, Jacob Gutsche, Maureen Burke-Julien, et al.
JACC. Cardiovascular Interventions|August 20, 2018
The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 RegistryRebecca T Hahn, Philippe Pibarot, Jonathon Leipsic, et al.
American Heart Journal|September 26, 2006
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30)C Michael Gibson, Ajay J Kirtane, David A Morrow, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2017
Outcomes, readmissions, and costs in transfemoral and alterative access transcatheter aortic valve replacement in the US Medicare populationFenton H McCarthy, Danielle D Spragan, Danielle Savino, et al.
JACC. Cardiovascular Interventions|April 23, 2021
Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT TrialRim Halaby, Howard C Herrmann, Zachary M Gertz, et al.
Herz|July 15, 2016
[Assessment of subjective physical well-being in heart failure : Validation of the FEW16 questionnaire]D Jahandar Lashki, C Zelenak, E Tahirovic, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2017
Cost and contribution margin of transcatheter versus surgical aortic valve replacementFenton H McCarthy, Danielle C Savino, Chase R Brown, et al.
Pageof 61